The biochip market in India is expected to reach a projected revenue of US$ 1,433.9 million by 2033. A compound annual growth rate of 15.1% is expected of India biochip market from 2026 to 2033.
The India biochip market generated a revenue of USD 451.2 million in 2025 and is expected to reach USD 1,433.9 million by 2033.
The India market is expected to grow at a CAGR of 15.1% from 2026 to 2033.
In terms of segment, lab-on-chip was the largest revenue generating type in 2025.
Lab-on-chip is the most lucrative type segment registering the fastest growth during the forecast period.
Biochip market data book summary
Market revenue in 2025
USD 451.2 million
Market revenue in 2033
USD 1,433.9 million
Growth rate
15.1% (CAGR from 2026 to 2033)
Largest segment
Lab-on-chip
Fastest growing segment
Lab-on-chip
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
DNA Chips, Lab-on-chip, Tissue Arrays, Protein Chips, Cell Arrays
Key market players worldwide
Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox
Other key industry trends
In terms of revenue, India accounted for 2.9% of the global biochip market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, Japan biochip market is projected to lead the regional market in terms of revenue in 2033.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,433.9 million by 2033.
Organizations in the country are undertaking initiatives to ensure that professionals are aware of the new genomic technologies introduced in the market. For example, Genomics India works very closely on personalized diagnostics, genomics for healthcare, genomics & data analytics, genomics in breeding & agriculture, and genomics to improve society.
The expanding pool of local market entities is further expected to propel the growth of India genomics market in the coming years. Over the past few decades, India has become a hub for pharmaceutical and biotechnology and has gained global attention due to the presence of skilled & knowledgeable manpower and low capital investments.
Owing to the presence of rich resources and a large pool of existing R&D institutions in the country, India has become one of the key areas for setting up research laboratories & manufacturing units by multinational companies.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biochip Market will help companies and investors design strategic landscapes.
Lab-On-Chip was the largest segment with a revenue share of 45.41% in 2025.
Horizon Databook has segmented the India biochip market based on dna chips, lab-on-chip, tissue arrays, protein chips, cell arrays covering the revenue growth of each sub-segment from 2021 to 2033.
Organizations in the country are undertaking initiatives to ensure that professionals are aware of the new genomic technologies introduced in the market. For example, Genomics India works very closely on personalized diagnostics, genomics for healthcare, genomics & data analytics, genomics in breeding & agriculture, and genomics to improve society.
The expanding pool of local market entities is further expected to propel the growth of India genomics market in the coming years. Over the past few decades, India has become a hub for pharmaceutical and biotechnology and has gained global attention due to the presence of skilled & knowledgeable manpower and low capital investments.
Owing to the presence of rich resources and a large pool of existing R&D institutions in the country, India has become one of the key areas for setting up research laboratories & manufacturing units by multinational companies.
India Biochip Market Type Outlook (Revenue, USD Million , 2021-2033)
DNA Chips
Protein Chips
Lab-on-chip
Tissue Arrays
Cell Arrays
India Biochip Market End Use Outlook (Revenue, USD Million , 2021-2033)
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostics Centers
Academic & Research Institutes
Others
Reasons to subscribe to biochips market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of biochips market databook
Our clientele includes a mix of biochips market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India biochips market, including forecasts for subscribers. This country databook contains high-level insights into India biochips market from 2021 to 2033, including revenue numbers, major trends, and company profiles.